Results 111 to 120 of about 2,116 (170)

Risk assessment of asthma and allergic rhinitis in atopic dermatitis patients treated with biologics and JAK inhibitors: a systematic review and network meta-analysis of randomized controlled trials. [PDF]

BMC Med
Zeng L, Zhou T, Zhang L, Xian M, Zhu Z, Liu J, Fu S, Luo H, Li J.   +8 more
europepmc   +1 more source

Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis. [PDF]

J Eur Acad Dermatol Venereol
Gooderham M, Ameen M, Hong HC, Katoh N, Langley RG, Peris K, Reich K, Silvestre JF, Simpson E, Werfel T, Gjerum L, Tindberg AM, Øland CB, Blauvelt A.   +13 more
europepmc   +1 more source

Transitioning from Cyclosporine to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World Comparison of Direct Switch vs. Short Overlap. [PDF]

J Pers Med
Ureña-Paniego C, Sanabria-de la Torre R, Arias-Santiago S, Montero-Vílchez T.   +3 more
europepmc   +1 more source

Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry. [PDF]

Allergy
van der Gang LF, Boesjes CM, Zuithoff NPA, Haeck I, Bacoş-Cosma O, Loman L, Atash K, Harbers V, Stadhouders S, Oosting AJ, van Lynden-van Nes AMT, Politiek K, Gostynski A, Christoffers WA, Garritsen FM, Flinterman A, Touwslager WRH, Velstra B, Stewart SM, van Erp FC, Galimont-Collen AFS, Schuttelaar MA, de Graaf M, de Bruin-Weller MS.   +23 more
europepmc   +1 more source

Mycosis fungoides unmasked by tralokinumab treatment for atopic dermatitis

JAAD Case Reports
Sanah Basrai, BA, Alexander R. Gomez-Lara, BA, BS, Dante Dahabreh, MD, Sebastien De Feraudy, MD, PhD, Eunice Y. Tsai, MD, Patrick E. McCleskey, MD   +5 more
doaj   +1 more source

Effectiveness and safety of tralokinumab in a patient with severe atopic dermatitis and hepatitis B virus. [PDF]

An Bras Dermatol
Olivares-Guerrero M, Jiménez-Sánchez A, Aparicio-Domínguez M, Chicharro P.   +3 more
europepmc   +1 more source

Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitors. [PDF]

Skin Health Dis
Ippoliti E, Gori N, Coscarella G, Antonelli F, Cannizzaro MV, Peris K.   +5 more
europepmc   +1 more source

Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study. [PDF]

JAAD Int
Anand P, Mostaghimi A, Glynn R, Jin Y, Merola JF, Silverberg JI, Rosmarin DM, Sidbury R, Landon J, Schneeweiss MC.   +9 more
europepmc   +1 more source

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. [PDF]

Am J Clin Dermatol
Mayo T, Silverberg JI, Armstrong A, Guttman-Yassky E, Blauvelt A, Esdaile B, Kabashima K, Gooderham M, Kircik L, Schneider S, Bennike N, von Eyben R, Martel BC, Røpke MA, Katoh N, Alexis AF.   +15 more
europepmc   +1 more source